Primary Fibrosarcoma of the Liver: We Don’t Know Much
نویسندگان
چکیده
منابع مشابه
Primary Fibrosarcoma of the Liver: We Don't Know Much
A 60-year-old lady presented to us with a right upper abdominal mass. With a clinical diagnosis of liver tumor, she was evaluated with abdominal CT, MRI, nuclear scan, tumor markers, USG guided FNAC and other baseline investigations. On evaluation she had a massive right lobe tumor crossing the midline. In view of the ambiguous diagnosis she was subjected to laparotomy where the lesion was judg...
متن کاملNonhost resistance: how much do we know?
Nonhost disease resistance is the most common form of disease resistance exhibited by plants against the majority of potentially pathogenic microorganisms. Recently, several components of nonhost disease resistance have been identified. Nonhost resistance exhibited against bacteria, fungi and oomycetes can be of two types. Type I nonhost resistance does not produce any visible symptoms whereas ...
متن کاملChildhood urinary stones induced by melamine-tainted formula: how much we know, how much we don't know.
Through screening, diagnosing, and treating childhood urinary stones induced by melamine-tainted formula, Chinese doctors obtained more experience with the clinical as well as the imaging features of the stones, although there still are many questions regarding melamine-associated stones. By reviewing the earlier reports on animals along with our recent experiences with humans, we concluded tha...
متن کاملSuperior Capsule Reconstruction: What Do We Know?
The management of irreparable rotator cuff tears remains challenging. Since its introduction by Mihata in 2012, superiorcapsule reconstruction (SCR) has grown in popularity at an astonishingly rapid rate. The aim of this article is to providea comprehensive review of the available literature, in order to highlight what has so far been published on SCR,covering all aspects including biomechanica...
متن کاملStatin treatment in the elderly: how much do we know?
Cardiovascular disease (CVD) risk increases progressively with advancing age [1]. Yet life expectancy has increased [2]. In Europe the average life expectancy at birth has risen from around 45 years in the 1900s to 75.1 years in 2005–2010, and it is expected to rise to 85.3 years for women and 80.0 years for men [3, 4]. Approximately 34 million Americans are currently ≥ 65 years of age and this...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Case Reports in Gastroenterology
سال: 2008
ISSN: 1662-0631
DOI: 10.1159/000161563